Virbac (CHIX:VIRPP) Interest Income : €6 Mil (TTM As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Virbac Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Virbac's interest income for the six months ended in Dec. 2024 was €3 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was €6 Mil.

Virbac Interest Income Historical Data

The historical data trend for Virbac's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Interest Income Chart

Virbac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Income

Get a 7-Day Free Trial

2.02

2.37

4.83

8.72

6.39

Virbac Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Income	Get a 7-Day Free Trial															3.25	4.12	4.60	3.50	2.89

Virbac Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €6 Mil.

Virbac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (CHIX:VIRPp) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

VRBCF:USA 0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.

Virbac Headlines

No Headlines